Universe Pharmaceuticals INC Hosts Reception for Member of Chinese Academy of Engineering and Expert Group from Tianjin University of Traditional Chinese Medicine
July 26 2021 - 8:00AM
Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a
pharmaceutical producer and distributor in China, today announced
the Company hosted a reception on July 20, 2021 for Mr. Boli Zhang,
a member of the Chinese Academy of Engineering, and a group of
experts from Tianjin University of Traditional Chinese Medicine.
Representatives from the local government also attended the
reception, including Mr. Zhibin Liu, deputy mayor of Ji'an City,
and Mr. Runjin Peng, head of Ji'an County.
Mr. Boli Zhang and the experts visited the
Company’s production facilities, and Mr. Gang Lai, Chairman and CEO
of the Company, introduced the Company’s core product, Guben
Yanling Pill during the reception. Mr. Boli Zhang and the experts
thought highly of the Company's achievements in bringing health
benefits to people and society.
Mr. Boli Zhang stated, “Guben Yanling Pill is a
product made from ginseng, ophiopogon japonicus and schisandra
chinensis in Shengmaiyin, and other medicinal materials good for
kidney function. Furthermore, it helps relieving fatigue,
palpitation, low back pain and general weakness and soreness, and
addresses the common symptoms experienced by middle-aged and
elderly people. With the gradually increasing aging population and
consumption upgrades, Guben Yanling Pill has huge market potential,
especially in the Southeast Asian market.”
Mr. Gang Lai, Chairman and CEO of Universe
Pharmaceuticals INC, commented, “I would like to thank Mr. Boli
Zhang and the experts from Tianjin University of Traditional
Chinese Medicine for pointing out the direction for our
technological innovation in the future. We expect to strengthen our
research and development efforts, accelerate the construction of
our research and development platform, explore technological
cooperation with industry partners, and cooperate closely with Mr.
Boli Zhang’s team so as to bring our technological innovation to a
higher level.”
About Universe Pharmaceuticals INC
Universe Pharmaceuticals INC, headquartered in
Ji’an, Jiangxi, China, is a pharmaceutical producer and distributor
in China. The Company specializes in the manufacturing, marketing,
sales and distribution of traditional Chinese medicine derivatives
products targeting the elderly with the goal of addressing their
physical conditions in the aging process and to promote their
general well-being. The Company also distributes and sells
biomedical drugs, medical instruments, Traditional Chinese Medicine
Pieces, and dietary supplements manufactured by third-party
pharmaceutical companies. Currently, the Company’s products are
sold in 30 provinces of China. For more information, visit the
company’s website at http://www.universe-pharmacy.com/.
Forward-Looking Statements
All statements other than statements of
historical fact in this announcement are forward-looking
statements. These forward-looking statements involve known and
unknown risks and uncertainties and are based on current
expectations and projections about future events and financial
trends that the Company believes may affect its financial
condition, results of operations, business strategy and financial
needs. Investors can identify these forward-looking statements by
words or phrases such as "may," "will," "expect," "anticipate,"
"aim," "estimate," "intend," "plan," "believe," "potential,"
"continue," "is/are likely to" or other similar expressions. The
Company undertakes no obligation to update forward-looking
statements to reflect subsequent occurring events or circumstances,
or changes in its expectations, except as may be required by law.
Although the Company believes that the expectations expressed in
these forward-looking statements are reasonable, it cannot assure
you that such expectations will turn out to be correct, and the
Company cautions investors that actual results may differ
materially from the anticipated results and encourages investors to
review other factors that may affect its future results in the
Company’s registration statement and in its other filings with the
SEC.
For more information, please contact:
Ascent Investors Relations LLCTina
XiaoPresidentPhone:
917-609-0333Email: tina.xiao@ascent-ir.com
Universe Pharmaceuticals (NASDAQ:UPC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Universe Pharmaceuticals (NASDAQ:UPC)
Historical Stock Chart
From Jul 2023 to Jul 2024